Syros Pharmaceuticals Inc (NASDAQ:SYRS)

4.55
Delayed Data
As of Oct 15
 -0.08 / -1.73%
Today’s Change
4.00
Today|||52-Week Range
15.65
-58.06%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 23.00 and a low estimate of 9.00. The median estimate represents a +295.60% increase from the last price of 4.55.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.44
Sales
$4.5M
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.53%
 
 
 
 
 
 
Growthannually 16.76%
 
 
 
 
 
 

Sales

Growthquarterly -13.03%
 
 
 
 
 
 
Growthannually 25.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.